JANE KIM: Open Payments
NPI 1881255933 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 97 payments from 10 companies in 2025. Trend: 2023 $1,727 · 2024 $2,052 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $619 |
| Janssen Biotech, Inc. | 25 | $418 |
| Aimmune Therapeutics, Inc. | 14 | $256 |
| GENZYME CORPORATION | 4 | $109 |
| Intercept Pharmaceuticals, Inc. | 4 | $73 |
| Madrigal Pharmaceuticals | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Braintree Laboratories, Inc. | 2 | $61 |
| Lilly USA, LLC | 2 | $49 |
| Dexcom, Inc. | 1 | $25 |
Products named: TREMFYA, RINVOQ, SKYRIZI, VOWST, DUPIXENT, OCALIVA, REZDIFFRA, ZENPEP.
Industry payments across CA — which companies pay providers there.
